Drug access, reimbursement, patient advocacy
2026 · 3rd Quarter (July 1 - Sep 30)
NEW ENGLAND RESEARCH GROUP
Filed by NEW ENGLAND RESEARCH GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Aug 26, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- NEW ENGLAND RESEARCH GROUP
- Filing UUID
- a6d2d871-1f27-4607-8648-bce29743913d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Drug access, reimbursement, patient advocacy
Drug access, reimbursement, patient advocacy
Drug access, reimbursement, patient advocacy
Drug access, reimbursement, patient advocacy
Drug access, reimbursement, patient advocacy
Drug access, reimbursement, patient advocacy
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.